Nachrichten zur Penumbra Inc. Aktie

Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?

Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend…

Penumbra stock rises following Strykers Inari Medical acquisition By Investing.com

Penumbra stock rises following Strykers Inari Medical acquisition…

Is Penumbra Stock a Smart Buy for Your Portfolio Right Now?

PEN stays on investors radars due to its robust portfolio expansion and international growth plans.…

Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript

…

Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market

The third-quarter results reflect another strong performance by Penumbras U.S. thrombectomy business.…

Why Penumbra Stock Zoomed 4% Higher Today

The latest news from the lab, plus an analysts bullish move, combined to put some zip in the companys shares.…

Why Penumbra Stock Zoomed Nearly 5% Higher Today

The company might just be the right kind of business operating at the right time in history.…

PEN Stock to Gain From CE Mark Approval for its CAVT Technologies

Penumbra receives the CE Mark approval for Lightning Flash 2.0 and Lightning Bolt 7 in Europe.…

Penumbra, Inc. (PEN) Q2 2024 Earnings Call Transcript

…

Penumbra (PEN) Soars 3.3%: Is Further Upside Left in the Stock?

Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend…

Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand

Penumbras (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.…

Penumbras (PEN) New Launch to Enhance Blood Clot Removal

Penumbras (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.…

Penumbra (PEN) Gains From Innovation, Mounting Costs Ail

Penumbra (PEN) expects to materially increase both revenues and profitability in the companys international business in the next three years…

Penumbra (PEN) Q4 Earnings Top Estimates, Margins Increase

Penumbras (PEN) Q4 revenues register year-over-year growth driven by robust U.S. thrombectomy sales.…

Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript

…

Penumbra (PEN) Rides on Vascular Arm Strength Amid FX Woes

Penumbras (PEN) Vascular business is demonstrating strong growth, banking on a rapid increase in sales of vascular thrombectomy products in…

5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024

Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue…

Penumbra (PEN) Stock Up 16.2% YTD: Will the Rally Continue?

Investors are optimistic about Penumbra (PEN), driven by growth in the vascular segments and upbeat guidance.…

Heres Why You Should Invest in Penumbra (PEN) Stock Now

Investors are optimistic about Penumbra (PEN), which is led by growth in vascular and neuro businesses.…

Penumbra (PEN) Enrolls First Patient in Landmark STORM-PE Trial

Penumbra (PEN) achieves an important milestone by enrolling the first patient in STORM-PE RCT.…

Penumbras (PEN) Expansion Moves, New Launches Aid Growth

Penumbra (PEN) expects to materially increase both revenues and profitability of the international business in the next three years and…

Heres Why You Should Retain Penumbra (PEN) Stock for Now

Investors are optimistic about Penumbra (PEN) on strong vascular and neuro businesses growth and upbeat guidance.…

Penumbra, Inc. (PEN) Q3 2023 Earnings Call Transcript

…

Penumbra (PEN) Q3 Earnings Top Estimates, Margins Increase

Penumbras (PEN) vascular and neuro product categories continue to show encouraging growth trends.…

Penumbra (PEN) to Report Q3 Earnings: Whats in the Cards?

Penumbra (PEN) will likely report strong Neuro sales growth on the strength of its RED 72 (with the proprietary SENDit…

Belluscura receives 89.6p midpoint valuation from Stonegate Capital

Belluscura has received an 89.6p ($1.09, GBP/USD: 1.2164) midpoint valuation from Stonegate Capital in a research note issued last week.…

Microcatheter Market to Hit US$ 1,259.78 Million By 2031 | Research By Consegic Business Intelligence

Consegic Business Intelligence analyzes that the microcatheter market is growing with a healthy CAGR of 5.1% during the forecast period…

Insiderhandel: CEO and President verkauft Aktien von Penumbra im Wert von 2.389.574$

Elsesser, Adam - Vorstand - Tag der Transaktion: 2023-08-11...…

Form 8-K/A Penumbra Inc For: May 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Penumbra (PEN) Q2 Earnings Top Estimates, Sales View Raised

Penumbras (PEN) U.S. thrombectomy records 50% year-over-year growth, while the international Vascular business sees relatively flat sales in the second…

Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 53.57% and 3.28%, respectively, for the quarter ended June 2023. Do the…

Form 10-Q Penumbra Inc For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Penumbra GAAP EPS of $0.48 beats by $0.20, revenue of $261.5M beats by $8.25M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Penumbra, Inc. Reports Second Quarter 2023 Financial Results

ALAMEDA, Calif., Aug. 1, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today…

Zacks Industry Outlook Highlights Alcon, Hologic and Penumbra

Alcon, Hologic and Penumbra have been highlighted in this Industry Outlook article....…

Baird starts Penumbra at outperform, citing revenue growth potential

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: CEO and President verkauft Aktien von Penumbra im Wert von 3.121.956$

Elsesser, Adam - Vorstand - Tag der Transaktion: 2023-07-11...…

Penumbra (PEN) Gains on New Launches Amid Currency Headwind

Penumbras (PEN) ability to improve net gross margins and EPS amid ongoing inflationary pressure and supply-chain headwinds buoy optimism....…

Insiderhandel: EVP, Gen. Counsel & Secretary verkauft Aktien von Penumbra im Wert von 306.163$

Roberts, Johanna - Vorstand - Tag der Transaktion: 2023-07-03...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Penumbra im Wert von 9.219$

Sarna, Surbhi - Aufsichtsrat - Tag der Transaktion: 2023-07-03...…

Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023

ALAMEDA, Calif., July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call…

Zacks.com featured highlights Penumbra, Trip.com, Transportadora de Gas del Sur and Vipshop

Penumbra, Trip.com, Transportadora de Gas del Sur and Vipshop have been highlighted in this Screen of The Week article....…

Buy These 4 Low-Beta Stocks to Counter the Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Trip.com Group…

Insiderhandel: CEO and President verkauft Aktien von Penumbra im Wert von 3.136.481$

Elsesser, Adam - Vorstand - Tag der Transaktion: 2023-06-12...…

Zacks.com featured highlights include Penumbra, Lamb Weston Holdings, Transportadora de Gas del Sur and Vipshop

Penumbra, Lamb Weston Holdings, Transportadora de Gas del Sur and Vipshop are part of the Zacks Screen of the Week…

Buy These 4 Low-Beta Stocks to Sail Through Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Lamb Weston…

Penumbra (PEN) Launches New Technology for Blood Clot Removal

Penumbra (PEN) launches Lightning Bolt 7, a new technology that can remove blood clots faster and more efficiently with modulated…